Rehabilitationszentrum Klinik Valens
Valens, Canton of St. Gallen, CH- 7317, Switzerland
NCT Number: NCT04896905
The aim of the study is to gain insight into the rehabilitation process and predictive factors for the outcome after rehabilitation in three patient groups:
1. SARS-CoV-2-positive patients in the isolation ward 2. Post-Covid-19 patients 3. Control group; matched for gender, age and co-morbidity
Looking for future studies?
Notify Me40 year–100 year
All sexes
Observational
Valens, Canton of St. Gallen, CH- 7317, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Rehabilitative procedures in isolation ward
Time frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Timed Up and Go-Test TUG (Seconds; less=better, normal <10 Sec.)
Time frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
FIM at entry and discharge (min 18, max 126 points; higher level= better functioning; )
Time frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Level of patient self rated functioning in daily activities (higher level= better self related functioning)
Time frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
EQ5D- VAS (0-100; higher level = better quality of life)
Klinik Valens
Other
Rehabilitation After Covid19-Clinical Results and Predictive Factors for Rehabilitation Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04747249
COVID-19, Coronaviridae Infections
Caen, France
View Trial DetailsNCT04924881
COVID-19, Coronaviridae Infections
Shatin, Hong Kong
View Trial DetailsNCT04939506
Behavior, COVID-19
New Orleans, Louisiana, United States
View Trial DetailsNCT04705116
COVID-19, Coronaviridae Infections
Los Angeles, California, United States
View Trial Details